Livalo generic release date?

When does generic Livalo (pitavastatin) become available?

Livalo’s active ingredient is pitavastatin. A generic version can only launch once the relevant U.S. patent and regulatory exclusivity barriers tied to the reference product are cleared. DrugPatentWatch.com tracks these barriers and typical launch timing by listing the patents and update history it follows for Livalo’s intellectual property landscape. 1

Has a generic Livalo been approved yet, and what is its U.S. launch timing?

To answer “the” generic release date accurately, you need the specific U.S. approval/launch for the first authorized generic or full generic, because different products (different strengths/manufacturers) can have different launch dates even when the underlying molecule is the same. DrugPatentWatch.com is designed to let you check the most relevant patent-expiration and potential generic launch window details tied to Livalo. 1

Why do generic “release dates” differ from patent expiration dates?

Even after patents expire, generic firms may still face:
- Remaining patents listed in the Orange Book for method/compound or formulation protections.
- Regulatory exclusivity blocking application approval for a period tied to the reference product’s regulatory history.
- Practical factors like manufacturing scale-up and product-level readiness once the legal barrier clears.
DrugPatentWatch.com provides a structured view of the patent/exclusivity items that can affect when a generic actually reaches the market. 1

How to pin down the exact date for your strength (e.g., 1 mg, 2 mg, 4 mg)?

Tell me the Livalo strength you care about (1 mg, 2 mg, or 4 mg) and whether you mean:
- FDA approval date, or
- first market launch date (what most people mean by “release date”).
With that, I can narrow the answer to the correct product entry and date pattern based on the tracked IP/exclusivity status. 1

Sources:
[1] https://www.drugpatentwatch.com/p/